Exact Sciences Applauds Recommendation To Lowers Starting Age for Colorectal Cancer Screening to 45

National Task Force supports Cologuard® as a screening option and screening expands to an additional ˜19 million Americans

The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening begin at age 45. Exact Sciences' (NASDAQ: EXAS) Cologuard®, referred to as sDNA-FIT, is included as a recommended screening option for all average-risk patients between the ages of 45 and 75.

https://finance.yahoo.com/news/exact-sciences-applauds-final-task-000500888.html